Pharmaceutical Technology
JUNE 6, 2023
Don’t miss the special thematic supplement that inspects the evolving role of cybersecurity in the pharmaceutical industry. Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
World of DTC Marketing
NOVEMBER 9, 2020
SUMMARY: Patient influencers trust social media groups more than pharma websites for health information, according to a survey from Wego Health. Imagine a survey like this from a company that specializes in patient influencers. Only 3% said they prefer pharma websites” The key here is the term “influencers.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
MARCH 22, 2024
We’re featuring AI in this month’s issue as the topic can’t be ignored—generative AI is creating huge waves in the Pharma industry and it’s all we’re talking about. There are ethical considerations around AI in Pharma, from protecting intellectual property, to providing accurate information, to programming bias, to name a few.
World of DTC Marketing
MAY 17, 2021
The last Prevention Magazine study indicated that 7% of DTC TV ads effectively drove patients to ask for/about a medication. NOBODY goes to a pharma website and says “I’m going to ask for that drug!” Pharma websites need to evolve. Targeted in the right publications, print ads can be a great DTC marketing tool.
Pharma Marketing Network
JULY 7, 2021
At this year’s Pharma USA conference, C ollaboration was the theme of the opening keynote session and a common thread woven throughout the event as industry leaders gathered to discuss how to move “Beyond Normal” to shape the future of health. Collaboration in Action. Build & Scale. Keeping Patients at the Center of Care.
Pharma Marketing Network
JANUARY 18, 2023
Partner at Rebound Communications, a firm that specializes in Commercial Acceleration for tech and data companies in life sciences and healthcare. Rebound was recently recognized by Inc Magazine as one of America’s 5000 fastest-growing private companies, coming in at #702 on the list with 893% growth over the past three years.
Clarivate
MAY 24, 2022
Multinational pharmas seek entry for their products. Multinational pharmas have taken notice of the recent policy focus of Mainland China’s healthcare authorities on rare diseases. China’s rapidly evolving and increasingly dynamic rare disease market provides pharmas an opportunity for strong growth. The Lancet. 2019; 2:8-15. (in
Expert insights. Personalized for you.
52 
Let's personalize your content